Resveratrol and polydatin as modulators of Ca(2+) mobilization in the cardiovascular system (Q39406728)

11 September 2017

1 reference

title

Resveratrol and polydatin as modulators of Ca(2+) mobilization in the cardiovascular system (English)

1 reference

11 September 2017

Wenjuan Liu

1

1 reference

11 September 2017

Peiya Chen

2

1 reference

11 September 2017

Jianxin Deng

3

1 reference

11 September 2017

Jingzhang Lv

4

1 reference

11 September 2017

Jie Liu

5

1 reference

11 September 2017

language of work or name

English

0 references

publication date

30 June 2017

1 reference

Annals of the New York Academy of Sciences

11 September 2017

published in

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

11 September 2017

1 reference

Calcium signalling: dynamics, homeostasis and remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Decoding calcium signals involved in cardiac growth and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Integrated Ca(2+) signaling between smooth muscle and endothelium of resistance vessels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Paradoxical cellular Ca2+ signaling in severe but compensated canine left ventricular hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Calcium and arrhythmogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Role of Ca2+/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Cellular calcium homeostasis during ischemia; a thermodynamic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Calcium-mediated cell death during myocardial reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Plasma membrane calcium ATPase overexpression in arterial smooth muscle increases vasomotor responsiveness and blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Resveratrol and Omega-3 Fatty Acid: Its Implications in Cardiovascular Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Resveratrol and Cardiovascular Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Polydatin: a review of pharmacology and pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

An overview of the efficacy of resveratrol in the management of ischemic heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Resveratrol attenuates ventricular arrhythmias and improves the long-term survival in rats with myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Resveratrol ameliorates cardiac dysfunction induced by pressure overload in rats via structural protection and modulation of Ca(2+) cycling proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Cardiac excitation-contraction coupling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Allosteric activation of Na+-Ca2+ exchange by L-type Ca2+ current augments the trigger flux for SR Ca2+ release in ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

The red wine polyphenol, resveratrol, exerts acute direct actions on guinea-pig ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Structure of trans -Resveratrol in Complex with the Cardiac Regulatory Protein Troponin C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Effect of resveratrol on L-type calcium current in rat ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

beta-Adrenergic stimulation synchronizes intracellular Ca(2+) release during excitation-contraction coupling in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Functional regulation of L-type calcium channels via protein kinase A-mediated phosphorylation of the beta(2) subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Does load-induced ventricular hypertrophy progress to systolic heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Alterations in calcium handling in cardiac hypertrophy and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

CaMKII induces permeability transition through Drp1 phosphorylation during chronic β-AR stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Benidipine, a long-acting calcium channel blocker, inhibits cardiac remodeling in pressure-overloaded mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Continuous blockade of L-type Ca2+ channels suppresses activation of calcineurin and development of cardiac hypertrophy in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Amlodipine ameliorates myocardial hypertrophy by inhibiting EGFR phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Defining the role of calcium channel antagonists in heart failure due to systolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Side effects of calcium channel blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Cardioprotective effect of polydatin against ischemia/reperfusion injury: roles of protein kinase C and mito K(ATP) activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Resveratrol protects against lipopolysaccharide-induced cardiac dysfunction by enhancing SERCA2a activity through promoting the phospholamban oligomerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Oxidative stress-induced leaky sarcoplasmic reticulum underlying acute heart failure in severe burn trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Resveratrol, a polyphenol phytoalexin, protects against doxorubicin-induced cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Sarcoplasmic reticulum Ca2+ and heart failure: roles of diastolic leak and Ca2+ transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Abnormal intrastore calcium signaling in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Direct spectroscopic detection of molecular dynamics and interactions of the calcium pump and phospholamban.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Inhibition of Na⁺-H⁺ exchange as a mechanism of rapid cardioprotection by resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Sudden death due to cardiac arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Redox modification of ryanodine receptors contributes to sarcoplasmic reticulum Ca2+ leak in chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Adverse effects of class I antiarrhythmic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

The vasorelaxing effect of resveratrol on abdominal aorta from rats and its underlying mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

The progress of the research on cardio-vascular effects and acting mechanism of polydatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Cardiovascular effects and molecular targets of resveratrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Resveratrol Ameliorates Clonidine-Induced Endothelium-Dependent Relaxation Involving Akt and Endothelial Nitric Oxide Synthase Regulation in Type 2 Diabetic Mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Resveratrol improves myocardial perfusion in a swine model of hypercholesterolemia and chronic myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Endothelium-dependent and-independent relaxation induced by resveratrol in rat superior mesenteric arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Resveratrol decreases calcium sensitivity of vascular smooth muscle and enhances cytosolic calcium increase in endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Effects of trans- and cis-resveratrol on Ca2+ handling in A7r5 vascular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

Trans- and cis-resveratrol increase cytoplasmic calcium levels in A7r5 vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

New approach to treatment of shock--restitution of vasoreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.13386

21 January 2018

Identifiers

DOI

10.1111/NYAS.13386

1 reference

11 September 2017

1 reference